Meanwhile, activated PPARγ exerted a protective role in the early inflammatory phase of aortic valve disease induced by hyperlipidemia, suggesting PPARγ as a putative drug target for aortic valve disease. The gene discussed is PPARG; the disease is aortic valve disorder.